Armor Investment Advisors LLC Buys 214 Shares of Becton, Dickinson and Company (NYSE:BDX)

Armor Investment Advisors LLC raised its stake in shares of Becton, Dickinson and Company (NYSE:BDX) by 2.9% in the 4th quarter, Holdings Channel reports. The firm owned 7,562 shares of the medical instruments supplier’s stock after purchasing an additional 214 shares during the quarter. Armor Investment Advisors LLC’s holdings in Becton, Dickinson and Company were worth $1,716,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of BDX. Livelsberger Financial Advisory bought a new position in shares of Becton, Dickinson and Company in the 3rd quarter worth about $26,000. Ashton Thomas Securities LLC bought a new position in shares of Becton, Dickinson and Company in the 3rd quarter worth about $33,000. Tompkins Financial Corp raised its position in shares of Becton, Dickinson and Company by 44.2% in the 3rd quarter. Tompkins Financial Corp now owns 150 shares of the medical instruments supplier’s stock worth $36,000 after acquiring an additional 46 shares in the last quarter. Sound Income Strategies LLC raised its position in shares of Becton, Dickinson and Company by 35.8% in the 3rd quarter. Sound Income Strategies LLC now owns 167 shares of the medical instruments supplier’s stock worth $40,000 after acquiring an additional 44 shares in the last quarter. Finally, Kennebec Savings Bank bought a new position in shares of Becton, Dickinson and Company in the 3rd quarter worth about $46,000. 86.97% of the stock is owned by institutional investors.

Insider Buying and Selling at Becton, Dickinson and Company

In other Becton, Dickinson and Company news, Director Jeffrey William Henderson bought 1,500 shares of the business’s stock in a transaction dated Monday, February 10th. The shares were purchased at an average price of $233.62 per share, for a total transaction of $350,430.00. Following the purchase, the director now directly owns 8,015 shares of the company’s stock, valued at approximately $1,872,464.30. This represents a 23.02 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP David Shan sold 500 shares of the business’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $240.00, for a total value of $120,000.00. Following the completion of the transaction, the executive vice president now owns 5,741 shares in the company, valued at $1,377,840. The trade was a 8.01 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 9,844 shares of company stock worth $2,210,716. Insiders own 0.36% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on the company. StockNews.com lowered Becton, Dickinson and Company from a “buy” rating to a “hold” rating in a research report on Wednesday, December 18th. Piper Sandler lifted their price objective on Becton, Dickinson and Company from $275.00 to $280.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 28th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $283.00.

Becton, Dickinson and Company Stock Performance

Shares of Becton, Dickinson and Company stock opened at $229.35 on Tuesday. The firm has a market capitalization of $66.51 billion, a price-to-earnings ratio of 38.10, a PEG ratio of 1.65 and a beta of 0.40. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.13 and a quick ratio of 0.74. Becton, Dickinson and Company has a one year low of $218.75 and a one year high of $251.99. The business has a 50-day simple moving average of $232.07 and a 200 day simple moving average of $234.02.

Becton, Dickinson and Company (NYSE:BDX) last released its quarterly earnings results on Wednesday, February 5th. The medical instruments supplier reported $3.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.00 by $0.43. Becton, Dickinson and Company had a return on equity of 15.74% and a net margin of 8.47%. On average, research analysts anticipate that Becton, Dickinson and Company will post 14.41 earnings per share for the current fiscal year.

Becton, Dickinson and Company declared that its Board of Directors has authorized a share repurchase program on Tuesday, January 28th that allows the company to repurchase 10,000,000 outstanding shares. This repurchase authorization allows the medical instruments supplier to reacquire shares of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.

Becton, Dickinson and Company Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 10th will be paid a dividend of $1.04 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $4.16 dividend on an annualized basis and a yield of 1.81%. Becton, Dickinson and Company’s dividend payout ratio (DPR) is currently 69.10%.

Becton, Dickinson and Company Profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.